Search for: "ELI LILLY & CO."
Results 961 - 980
of 1,007
Sorted by Relevance
|
Sort by Date
24 Nov 2015, 12:38 pm
Eli Lilly & Co., 620 F.3d 121 (2d Cir. 2010), which took home best decision in 2010 by reversing the second worst decision of 2008. [read post]
28 Apr 2013, 8:40 am
The Court did not move away from its previous ruling in Case C-4/03, Gesellschaft für Antriebstechnik mbH & Co. v Lamellen und Kupplungsbau Beteiligungs, which taught that a national court may assess infringement (or non-infringement) beyond national boundaries, but cannot rule on the validity of the patent at issue, as the courts of the member state where the patent was registered have exclusive jurisdiction on questions of validity, pursuant to the mandatory rule of Article 22(4)… [read post]
20 Dec 2023, 5:00 am
Major industry players filed amici briefs on both sides, AbbVie, Bristol Meyers Squibb, and Merck supporting Amgen, and Pfizer, Eli Lilly, Genentech, and AstraZeneca supporting Sanofi. [read post]
18 Nov 2016, 12:44 am
The judge held that the “undue burden” concept in English law (particularly as outlined by Arnold J in Eli Lilly v Janssen in 2014) was not particularly helpful under Australian law. [read post]
29 Jan 2021, 7:20 am
The second part of the summary will consider the “co-location” validity challenge made against a fourth patent. [read post]
31 Jul 2011, 9:28 pm
Co. v. [read post]
1 Feb 2013, 9:42 am
Mutual Pharmaceutical Co., 678 F.3d 30 (3d Cir.), cert. granted, 133 S.Ct. 694 (U.S. 2012). [read post]
18 Feb 2010, 10:34 am
Because those are federal statutes, they can’t be “preempted” the way state-law claims were in Buckman Co. v. [read post]
25 Jun 2009, 4:29 am
Eli Lilly & Co., 536 F.Supp.2d 767, 781 (S.D. [read post]
3 Jun 2010, 1:37 pm
Eli Lilly & Co., 854 N.E.2d 372 (Ind. [read post]
6 Jul 2007, 4:29 am
Upjohn Co., 778 A.2d 829, 836-38 (Conn. 2001); Coyle v. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
30 May 2008, 9:09 am
: (IP ThinkTank), (further discussion from IAM and e^(ip)) Illusory world of trade secret protection – Discussion of S Schreter’s article ‘Inside entrepreneurship: Patent protection isn’t only option’: (IPBiz) Global – Copyright Illegal art: (Patry Copyright Blog), Events 1-3 June: ACC Europe 2008 annual conference ‘Becoming a global legal manager: Developing the skills you will need to manage the… [read post]
18 Jul 2008, 8:34 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU Commission adopts proposal to extend copyright protection to performing artists from 50 to 95 years: (IPKat), (Out-Law), (IP Law360), (Patry Copyright Blog), (IPEG), (Techdirt), (Techdirt), ‘Triway’ USPTO, EPO, JPO patent work-sharing pilot starts 28 July: (IP Updates), (Patent Docs), (Patent Prospector), (EPO),… [read post]
18 Dec 2008, 10:36 pm
Eli Lilly & Co., 99 F.R.D. 126, 128 (D.D.C. 1983)). [read post]
21 May 2010, 8:58 am
Eli Lilly &Co. fell short of that requirement. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
12 Jun 2023, 1:09 pm
In scientific publishing, when scientists make a mistake, they publish an erratum or a corrigendum. [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
